Status: Recruiting
Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)
The Jacobs Institute is participating in a study designed to collect prospective clinical evidence to evaluate the approved use of the Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms
Participants needed: 10
Trial details
Age: 22+Biological sex: AllType: InterventionalSponsor: Jacobs instituteUpdated: Mar 10, 2026Locations: 1
Eligibility criteria
Adults (22 years of age or older) with large or giant wide-necked intracranial a...